Back
  1. Home
  2. Profile of Jacqueline Willems (ULiège)
Profil

Willems Jacqueline

See author's contact details
Main Referenced Co-authors
Hustinx, Roland  (21)
Jerusalem, Guy  (8)
Beckers, Catherine  (6)
Fassotte, Marie-France  (6)
Malaise, Michel  (6)
Main Referenced Keywords
Humans (6); Female (4); Aged (3); FDG (3); Male (3);
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (19)
Oncology (5)
Urology & nephrology (4)
Endocrinology, metabolism & nutrition (3)
Rheumatology (3)

Publications (total 30)

The most downloaded
1223 downloads
Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3 https://hdl.handle.net/2268/62381

The most cited

228 citations (Scopus®)

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964. https://hdl.handle.net/2268/5094

De Groote, D., Pincemail, J., Defraigne, J.-O., & Willems, J. (June 2007). Oral contraception and lipid peroxidation. Clinical Chemistry, 53 (6, Suppl. S), 30-A30.

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3
Peer Reviewed verified by ORBi

LETESSON, G., FOIDART-WILLEMS, J., & HUSTINX, R. (2005). FDG-PET imaging for diagnosing bone infection. Journal of Nuclear Medicine, 46 (SUPPL), 323.
Peer Reviewed verified by ORBi

Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., DRESSE, M.-F., Fassotte, M.-F., Paquet, N., Willems, J., Rigo, P., & Hustinx, R. (January 2005). F-18-FDG PET in children with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging, 32 (1), 31-38. doi:10.1007/s00259-004-1604-z
Peer Reviewed verified by ORBi

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.
Peer Reviewed verified by ORBi

Paquet, N., Albert, A., Willems, J., & Hustinx, R. (May 2004). Within-patient variability of F-18-FDG: Standardized uptake values in normal tissues. Journal of Nuclear Medicine, 45 (5), 784-788.
Peer Reviewed verified by ORBi

Delanaye, P., Radermecker, R., Saint-Remy, A., Chapelle, J.-P., Depas, G., Foidart, J., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation de la fonction rénale chez le patient anorexique [Poster presentation]. Congrès annuel de l’ALFEDIAM, Nice, France.

Delanaye, P., Demoulin, J.-C., Nellessen, E., Grosch, S., Saint-Remy, A., Foidart, J., Rorive, G., Lancellotti, P., & Krzesinski, J.-M. (2004). Intérêt de l’équation MDRD pour l’estimation du débit de filtration glomérulaire chez le patient greffé cardiaque [Poster presentation]. 5ème réunion commune de la Société de Néphrologie et de la Société Française de Dialyse, Nancy, France.

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Foidart, J., Krzesinski, J.-M., & Lancellotti, P. (2004). Is plasme cystatin C better than creatinine to detect renal failure in heart transplant recipients? [Paper presentation]. 41ème Congress of ERA-EDTA, Lisbonne, Portugal.

Hustinx, R., Lemaire, C., Jerusalem, G., Moreau, P., Cataldo, D., Duysinx, B., Aerts, J., Fassotte, M.-F., Foidart, J., & Luxen, A. (April 2003). Whole-body tumor imaging using PET and 2-18F-fluoro-l-tyrosine: Preliminary evaluation and comparison with 18F-FDG. Journal of Nuclear Medicine, 44 (4), 533-539.
Peer Reviewed verified by ORBi

BELHOCINE, T., THILLE, A., DE BARSY, C., KRIDELKA, F., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Added value of whole body 18FDG PET imaging in monitoring uterine cancers. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 269.
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.
Peer reviewed

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET imaging as a method for staging and early assessment of treatment response in pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 183.
Peer Reviewed verified by ORBi

Hustinx, R., Sautois, B., Jerusalem, G., & Foidart, J. (2003). Radiothérapie métabolique des douleurs osseuses métastatiques. Médecine et Hygiène, 61, 1560-1564.
Peer Reviewed verified by ORBi

PAQUET, N., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Intra-patient variability of SUV in normal tissues. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 327.
Peer Reviewed verified by ORBi

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET in the follow-up of pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 346.
Peer Reviewed verified by ORBi

Belhocine, T., Willems, J., Rigo, P., Najjar, F., Thiry, A., Quatresooz, P., & Hustinx, R. (August 2002). Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nuclear Medicine Communications, 23 (8), 727-734. doi:10.1097/00006231-200208000-00005
Peer Reviewed verified by ORBi

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38.
Peer Reviewed verified by ORBi

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38.
Peer Reviewed verified by ORBi

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.
Peer reviewed

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3
Peer Reviewed verified by ORBi

BECKERS, C., HUSTINX, R., FOIDART-WILLEMS, J., RIGO, P., & MALAISE, M. (2001). Glucose metabolism in rheumatoid arthritis knee joints before and after anti-TNF-apha blockade : evaluation by PET with 18-FDG. IN PROCEEDINGS ANNUAL AMI MEETING 2001, P56.
Peer reviewed

Rigo, P., Belhocine, T., Hustinx, R., & Foidart, J. (2000). TEP et tumeurs endocrines. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 24 (5), 275-282.
Peer reviewed

Geronooz, I., Scheen, A., & Foidart, J. (1999). Le diabete gestationnel: definition, depistage et traitement. Revue Médicale de Liège, 54 (5), 429-33.
Peer reviewed

HUSTINX, R., PAULUS, P., BURY, T., CATALDO, D., RIGO, P., & FOIDART-WILLEMS, J. (1997). Efficacy of Tc-99m P829, a radiolabelled somatostatin analog in visualising mediastinal spread of non-small cell lung cancer. European Journal of Nuclear Medicine, 24, 959.
Peer Reviewed verified by ORBi

Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Willems, J. (1997). Clinical PET in Oncology. In H. Bergmann, A. Kroiss, ... Sinzinger H (Eds.), Radioactive Isotopes in Clinical Medicine and Research (pp. 3-14). Basel, Switzerland: Birhauser Verlag.

Geenen, V., Foidart, J., & Krzesinski, J.-M. (20 June 1996). Un syndrome de Cushing d'origine inexpliquée. Actualité Médicale Belge, 513, 8.

Beckers, A., Pham, V. T., Abs, R., Foidart-Willems, J., & Meurisse, M. (1994). Localisation scintigraphique de tumeurs neuroendocrines et de leurs métastases par un analogue de la somatostatine: [111In-DTPA-d-phe1] octreotide. Médecine and Chirurgie Digestives, 23 (3), 145-150.
Peer Reviewed verified by ORBi

Beckers, A., Pham, V. T., Abs, R., Foidart, J., & Meurisse, M. (1993). Localisation scintigraphique de tumeurs neuroendocrines et de leurs métastases par un analogue de la somatostatine: [111In-DTPA-d-phe1] octréotide. Revue Médicale de Liège, 48 (6), 326-34.
Peer reviewed

Damas, P., Adam, A., Buret, J., Renard, C., Lamy, M., Foidart, J., & Mahieu, P. (1987). In-vivo studies on Haemaccel-fibronectin interaction in man. European Journal of Clinical Investigation, 17 (2), 166-73. doi:10.1111/j.1365-2362.1987.tb02396.x
Peer Reviewed verified by ORBi

Contact ORBi